Alejandro Katzin

Prof. Dr. Alejandro Katzin

University of São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
DADenise C. Arruda
Denise C. Arruda
FDFabio Luiz D'ALexandri
Fabio Luiz D'ALexandri
AKAlejandro Katzin
Alejandro Katzin
SUSílvia Reni Bortolin Uliana
Sílvia Reni Bortolin Uliana
The activity of nerolidol, a sesquiterpene used as a food-flavoring agent and currently under testing as a skin penetration enhancer for the transdermal delivery of therapeutic drugs, was evaluated againstLeishmaniaspecies. Nerolidol inhibited the growth ofLeishmania amazonensis,L. braziliensis, andL. chagasipromastigotes andL. amazonensisamastigotes with in vitro 50% inhibitory concentrations of 85, 74, 75, and 67 μM, respectively. The treatment ofL. amazonensis-infected macrophages with 100 μM nerolidol resulted in 95% reduction in infection rates. Inhibition of isoprenoid biosynthesis, as shown by reduced incorporation of [2-14C]mevalonic acid (MVA) or [1-14C]acetic acid precursors into dolichol, ergosterol, and ubiquinone, was observed in nerolidol-treated promastigotes. This drug effect can be attributed to the blockage of an early step in the mevalonate pathway, since incorporation of the precursor [1(n)-3H]farnesyl pyrophosphate in polyisoprenoids is not inhibited by nerolidol.L. amazonensis-infected BALB/c mice were treated with intraperitoneal doses of 100 mg/kg/day for 12 days or topically with 5 or 10% ointments for 4 weeks. Significant reduction of lesion sizes in nerolidol treated mice was observed for both treatment routes. However, long-term follow up indicated that the disease was not cured in this highly susceptible animal model. Nonetheless, the in vitro activity of nerolidol against these parasites may prove a useful tool for the development of new drugs for the treatment of leishmaniasis. In addition, biosynthesis of dolichols with 11 and 12 isoprene units was identified inLeishmania, as described for other trypanosomatids and Apicomplexa.

1 December 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MCMaría B. Cassera
María B. Cassera
FGFabio C. Gozzo
Fabio C. Gozzo
FDFabio L. D'ALexandri
Fabio L. D'ALexandri
EMEmilio F. Merino
Emilio F. Merino
HPHernando Del Portillo
Hernando Del Portillo
AKAlejandro Katzin
Alejandro Katzin
Two genes encoding the enzymes 1-deoxy-d-xylulose-5-phosphate synthase and 1-deoxy-d-xylulose-5-phosphate reductoisomerase have been recently identified, suggesting that isoprenoid biosynthesis in Plasmodium falciparum depends on the methylerythritol phosphate (MEP) pathway, and that fosmidomycin could inhibit the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase. The metabolite 1-deoxy-d-xylulose-5-phosphate is not only an intermediate of the MEP pathway for the biosynthesis of isopentenyl diphosphate but is also involved in the biosynthesis of thiamin (vitamin B1) and pyridoxal (vitamin B6) in plants and many microorganisms. Herein we report the first isolation and characterization of most downstream intermediates of the MEP pathway in the three intraerythrocytic stages of P. falciparum. These include, 1-deoxy-d-xylulose-5-phosphate, 2-C-methyl-d-erythritol-4-phosphate, 4-(cytidine-5-diphospho)-2-C-methyl-d-erythritol, 4-(cytidine-5-diphospho)-2-C-methyl-d-erythritol-2-phosphate, and 2-C-methyl-d-erythritol-2,4-cyclodiphosphate. These intermediates were purified by HPLC and structurally characterized via biochemical and electrospray mass spectrometric analyses. We have also investigated the effect of fosmidomycin on the biosynthesis of each intermediate of this pathway and isoprenoid biosynthesis (dolichols and ubiquinones). For the first time, therefore, it is demonstrated that the MEP pathway is functionally active in all intraerythrocytic forms of P. falciparum, and de novo biosynthesis of pyridoxal in a protozoan is reported. Its absence in the human host makes both pathways very attractive as potential new targets for antimalarial drug development.

1 July 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
HGHerbert Rodrigues Goulart
Herbert Rodrigues Goulart
EKEmília A. Kimura
Emília A. Kimura
VPValnice J. Peres
Valnice J. Peres
ACAlicia S. Couto
Alicia S. Couto
FDFulgencio A. Aquino Duarte
Fulgencio A. Aquino Duarte
AKAlejandro Katzin
Alejandro Katzin
Development of new drugs is one of the strategies for malaria control. The biosynthesis of several isoprenoids inPlasmodium falciparumwas recently described. Interestingly, some intermediates and final products biosynthesized by this pathway in mammals differ from those biosynthesized inP. falciparum. These facts prompted us to evaluate various terpenes, molecules with a similar chemical structure to the intermediates of the isoprenoids pathway, as potential antimalarial drugs. Different terpenes andS-farnesylthiosalicylic acid were tested on cultures of the intraerythrocytic stages ofP. falciparum, and the 50% inhibitory concentrations for each one were found: farnesol, 64 μM; nerolidol, 760 nM; limonene, 1.22 mM; linalool, 0.28 mM; andS-farnesylthiosalicylic acid, 14 μM. All the terpenes tested inhibited dolichol biosynthesis in the trophozoite and schizont stages when [1-(n)-3H]farnesyl pyrophosphate triammonium salt ([3H]FPP) was used as precursor. Farnesol, nerolidol, and linalool showed stronger inhibitory activity on the biosynthesis of the isoprenic side chain of the benzoquinone ring of ubiquinones in the schizont stage. Treatment of schizont stages withS-farnesylthiosalicylic acid led to a decrease in intensity of the band corresponding a p21rasprotein. The inhibitory effect of terpenes andS-farnesylthiosalicylic acid on the biosynthesis of both dolichol and the isoprenic side chain of ubiquinones and the isoprenylation of proteins in the intraerythrocytic stages ofP. falciparumappears to be specific, because overall protein biosynthesis was not affected. Combinations of some terpenes orS-farnesylthiosalicylic acid tested in this work with other antimalarial drugs, like fosmidomycin, could be a new strategy for the treatment of malaria.

1 November 1999 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Norberto Peporine LopesNorberto Peporine Lopes
Norberto Peporine Lopes
Massuo Jorge KatoMassuo Jorge Kato
Massuo Jorge Kato
EAEloisa Andrade
Eloisa Andrade
JMJosé G.S Maia
José G.S Maia
MYMassayoshi Yoshida
Massayoshi Yoshida
AKAlejandro Katzin
Alejandro Katzin

1 November 2009 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
DADenise C. Arruda
Denise C. Arruda
DMDanilo Ciccone MIguel
Danilo Ciccone MIguel
JYJenicer K.U. Yokoyama-Yasunaka
Jenicer K.U. Yokoyama-Yasunaka
AKAlejandro Katzin
Alejandro Katzin
SUSilvia R.B. Uliana
Silvia R.B. Uliana

1 September 2001 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
IMIvan Cruz Moura
Ivan Cruz Moura
GWGerhard Wunderlich
Gerhard Wunderlich
MUMaria L. Uhrig
Maria L. Uhrig
ACAlicia S. Couto
Alicia S. Couto
VPValnice J. Peres
Valnice J. Peres
EKEmı́lia A. Kimura
Emı́lia A. Kimura
Isoprenylation is an essential protein modification in eukaryotic cells. Herein, we report that in Plasmodium falciparum , a number of proteins were labeled upon incubation of intraerythrocytic forms with either [ 3 H]farnesyl pyrophosphate or [ 3 H]geranylgeranyl pyrophosphate. By thin-layer chromatography, we showed that attached isoprenoids are partially modified to dolichol and other, uncharacterized, residues, confirming active isoprenoid metabolism in this parasite. Incubation of blood-stage P. falciparum treated with the isoprenylation inhibitor limonene significantly decreased the parasites' progression from the ring stage to the trophozoite stage and at 1.22 mM, 50% of the parasites died after the first cycle. Using Ras- and Rap-specific monoclonal antibodies, putative Rap and Ras proteins of P. falciparum were immunoprecipitated. Upon treatment with 0.5 mM limonene, isoprenylation of these proteins was significantly decreased, possibly explaining the observed arrest of parasite development.